港股新药(513780)获融资买入0.18亿元，近三日累计买入0.42亿元

Core Viewpoint - The financing activities for Hong Kong New Drug (513780) indicate a modest interest from investors, with net buying observed over recent trading days [1] Financing Summary - On August 5, Hong Kong New Drug (513780) had a financing buy amount of 0.18 billion, ranking 879th in the market, with a financing repayment amount of 0.17 billion, resulting in a net buy of 1.0225 million [1] - Over the last three trading days (August 1-5), the financing buy amounts were 0.16 billion, 0.09 billion, and 0.18 billion respectively [1] Short Selling Summary - On August 5, there were no shares sold short for Hong Kong New Drug (513780), with net short selling also recorded at 0.00 shares [1]